Corin sounds profit warning due to Cormet slow-down
This article was originally published in Clinica
Executive Summary
Orthopaedic specialist Corin has warned investors that its pre-tax profit for fiscal 2008 will be "materially" lower than expected because of a drop in orders for its Cormet hip implants from US distributor Stryker. The Gloucester, UK-based firm said the number of Cormet implantations in 2008 were not enough for Stryker to re-order the devices in the fourth quarter. Corin added that Stryker (Kalamazoo, Michigan) would have enough implants in its existing inventory to cover its orders in the first fiscal quarter of 2009. As for the rest of 2009, Corin said Stryker would order extra implants as and when they were needed. The company also said that it does not expect its partner to purchase any more surgical instrumentation kits (needed to aid implantation of the Cormet device) during fiscal 2009.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals